Andrzej Friedman

3.5k total citations
85 papers, 2.5k citations indexed

About

Andrzej Friedman is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Andrzej Friedman has authored 85 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Neurology, 19 papers in Cellular and Molecular Neuroscience and 16 papers in Molecular Biology. Recurrent topics in Andrzej Friedman's work include Parkinson's Disease Mechanisms and Treatments (48 papers), Neurological disorders and treatments (37 papers) and Botulinum Toxin and Related Neurological Disorders (13 papers). Andrzej Friedman is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (48 papers), Neurological disorders and treatments (37 papers) and Botulinum Toxin and Related Neurological Disorders (13 papers). Andrzej Friedman collaborates with scholars based in Poland, United States and Israel. Andrzej Friedman's co-authors include Dariusz Koziorowski, Leszek Królicki, Anna Potulska‐Chromik, Stanley Fahn, Piotr Alster, Natalia Madetko‐Alster, Stanisław Szlufik, Ryszard Tomasiuk, Jarosław Sławek and E. R. Bauminger and has published in prestigious journals such as Neurology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Andrzej Friedman

82 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Friedman Poland 24 1.6k 586 537 387 378 85 2.5k
Rup Tandan United States 25 2.0k 1.2× 490 0.8× 696 1.3× 369 1.0× 541 1.4× 81 3.0k
Masato Asahina Japan 27 1.5k 0.9× 623 1.1× 745 1.4× 268 0.7× 429 1.1× 109 2.7k
Thibaud Lebouvier France 26 1.7k 1.0× 661 1.1× 617 1.1× 1.1k 2.9× 1.1k 3.0× 73 3.8k
Lonneke M.L. de Lau Netherlands 20 1.0k 0.6× 265 0.5× 354 0.7× 193 0.5× 342 0.9× 28 1.8k
Karen J. Kluin United States 27 759 0.5× 278 0.5× 720 1.3× 249 0.6× 440 1.2× 45 2.3k
Clifton L. Gooch United States 28 1.1k 0.7× 810 1.4× 440 0.8× 214 0.6× 741 2.0× 70 2.9k
Georgia Xiromerisiou Greece 28 1.3k 0.8× 495 0.8× 564 1.1× 485 1.3× 602 1.6× 100 2.4k
Spiridon Papapetropoulos United States 28 1.6k 1.0× 399 0.7× 663 1.2× 372 1.0× 477 1.3× 91 2.6k
Anna Zecchinelli Italy 24 1.1k 0.6× 209 0.4× 326 0.6× 156 0.4× 142 0.4× 46 1.5k

Countries citing papers authored by Andrzej Friedman

Since Specialization
Citations

This map shows the geographic impact of Andrzej Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Friedman more than expected).

Fields of papers citing papers by Andrzej Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Friedman. The network helps show where Andrzej Friedman may publish in the future.

Co-authorship network of co-authors of Andrzej Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Friedman. A scholar is included among the top collaborators of Andrzej Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Friedman. Andrzej Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figura, Monika, Stanisław Szlufik, A. Korn, et al.. (2024). Unilateral gamma knife thalamotomy for tremor safety and efficacy in multimodal assessment: a prospective case-control study with two-year follow-up. Neurologia i Neurochirurgia Polska. 58(3). 283–291. 3 indexed citations
2.
Madetko‐Alster, Natalia, Alicja Wiercińska‐Drapało, Dariusz Koziorowski, et al.. (2023). Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns. International Journal of Molecular Sciences. 24(20). 15135–15135. 16 indexed citations
3.
Alster, Piotr, et al.. (2022). The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes. Diagnostics. 12(7). 1671–1671. 1 indexed citations
4.
5.
6.
Alster, Piotr, Natalia Madetko‐Alster, & Andrzej Friedman. (2020). Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS). Neurologia i Neurochirurgia Polska. 55(1). 97–101. 26 indexed citations
7.
Alster, Piotr, Natalia Madetko‐Alster, Dariusz Koziorowski, & Andrzej Friedman. (2020). Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD). Frontiers in Neurology. 11. 180–180. 72 indexed citations
8.
Alster, Piotr, Natalia Madetko‐Alster, Dariusz Koziorowski, & Andrzej Friedman. (2020). Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP). Frontiers in Neuroscience. 14. 893–893. 47 indexed citations
9.
Jost, Wolfgang H., Andrzej Friedman, Olaf Michel, et al.. (2019). Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks. Parkinsonism & Related Disorders. 70. 23–30. 23 indexed citations
10.
Blitzer, Andrew, et al.. (2018). SIAXI: IncobotulinumtoxinA for sialorrhea in Parkinson’s disease, stroke, and other etiologies-Phase 3 Results (S30.007). Neurology. 90(15_supplement). 1 indexed citations
11.
Alster, Piotr, Dariusz Koziorowski, Stanisław Szlufik, et al.. (2018). Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes. Neurologia i Neurochirurgia Polska. 52(4). 459–464. 15 indexed citations
12.
Szlufik, Stanisław, et al.. (2017). The patient with mild diencephalic–mesencephalic junction dysplasia – Case report and review of literature. Neurologia i Neurochirurgia Polska. 51(6). 514–518. 2 indexed citations
13.
Jurek, Marta, et al.. (2014). Intrafamilial variability of the primary dystonia DYT6 phenotype caused by p.Cys5Trp mutation in THAP1 gene. Neurologia i Neurochirurgia Polska. 48(4). 254–257. 1 indexed citations
14.
Friedman, Andrzej, et al.. (2012). The history of the research of iron in parkinsonian substantia nigra. Journal of Neural Transmission. 119(12). 1507–1510. 26 indexed citations
15.
Koziorowski, Dariusz, et al.. (2011). Rodzinne występowanie zespołu FXTAS powodowanego premutacją w genie FMR1. Neurologia i Neurochirurgia Polska. 45(4). 391–396. 1 indexed citations
16.
Friedman, Andrzej, et al.. (2009). Poziom depresji w ostrej fazie udaru mózgu w zależności od lokalizacji ogniska niedokrwiennego w dominującej lub niedominującej półkuli mózgu. Via Medica Journals. 11(1). 1–8. 1 indexed citations
17.
Friedman, Andrzej, et al.. (2008). Paroxysmal Non-Kinesigenic Dyskinesia Caused by the Mutation of <i>MR-1</i> in a Large Polish Kindred. European Neurology. 61(1). 39–41. 6 indexed citations
18.
Sławek, Jarosław, Andrzej Friedman, Anna Potulska‐Chromik, et al.. (2007). Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.. CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche). 22(2). 95–100. 81 indexed citations
19.
Friedman, Andrzej, et al.. (2003). Quality of life in Polish patients with long‐lasting Parkinson's disease. Movement Disorders. 19(6). 667–672. 47 indexed citations
20.
Bauminger, E. R., et al.. (2003). Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1688(2). 130–136. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rup Tandan Breakdown of academic impact, for papers by Masato Asahina Breakdown of academic impact, for papers by Thibaud Lebouvier Breakdown of academic impact, for papers by Lonneke M.L. de Lau Breakdown of academic impact, for papers by Karen J. Kluin Breakdown of academic impact, for papers by Clifton L. Gooch Breakdown of academic impact, for papers by Georgia Xiromerisiou Breakdown of academic impact, for papers by Spiridon Papapetropoulos Breakdown of academic impact, for papers by Anna Zecchinelli
Rankless by CCL
2026